Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keybanc Maintains Overweight on Albemarle, Lowers Price Target to $132

Author: Benzinga Newsdesk | August 05, 2024 07:20am
Keybanc analyst Aleksey Yefremov maintains Albemarle (NYSE:ALB) with a Overweight and lowers the price target from $151 to $132.

Posted In: ALB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist